These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 26145818)
1. Synthesis and biological evaluation of isoflavone amide derivatives with antihyperlipidemic and preadipocyte antiproliferative activities. Wang W; He Y; Xu P; You Q; Xiao H; Xiang H Bioorg Med Chem; 2015 Aug; 23(15):4428-4433. PubMed ID: 26145818 [TBL] [Abstract][Full Text] [Related]
2. 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety. Smith CJ; Ali A; Chen L; Hammond ML; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Sinclair PJ Bioorg Med Chem Lett; 2010 Jan; 20(1):346-9. PubMed ID: 19914065 [TBL] [Abstract][Full Text] [Related]
3. 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice. Kallashi F; Kim D; Kowalchick J; Park YJ; Hunt JA; Ali A; Smith CJ; Hammond ML; Pivnichny JV; Tong X; Xu SS; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Peterson LB; Rosa R; Sparrow CP; Wright SD; Sinclair PJ Bioorg Med Chem Lett; 2011 Jan; 21(1):558-61. PubMed ID: 21094047 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors. Escribano A; Mateo AI; Martin de la Nava EM; Mayhugh DR; Cockerham SL; Beyer TP; Schmidt RJ; Cao G; Zhang Y; Jones TM; Borel AG; Sweetana SA; Cannady EA; Mantlo NB Bioorg Med Chem Lett; 2012 Jun; 22(11):3671-5. PubMed ID: 22543028 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antihyperlipidemic activity of piperic acid derivatives. A R; Bao N; Sun Z; Borjihan G; Qiao Y; Jin Z Nat Prod Commun; 2015 Feb; 10(2):289-90. PubMed ID: 25920263 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol ester transfer protein (CETP), postprandial lipemia and hypolipidemic drugs. Kolovou GD; Anagnostopoulou KK; Kostakou PM; Mikhailidis DP Curr Med Chem; 2009; 16(33):4345-60. PubMed ID: 19835569 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives. Sashidhara KV; Kumar A; Kumar M; Srivastava A; Puri A Bioorg Med Chem Lett; 2010 Nov; 20(22):6504-7. PubMed ID: 20932744 [TBL] [Abstract][Full Text] [Related]
8. Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy. Bellanger N; Julia Z; Villard EF; El Khoury P; Duchene E; Chapman MJ; Fournier N; Le Goff W; Guerin M Atherosclerosis; 2012 Mar; 221(1):160-8. PubMed ID: 22265126 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative evaluation of amide-containing flavone and isoflavone derivatives. Chen IL; Chen JY; Shieh PC; Chen JJ; Lee CH; Juang SH; Wang TC Bioorg Med Chem; 2008 Aug; 16(16):7639-45. PubMed ID: 18662883 [TBL] [Abstract][Full Text] [Related]
10. 2-Arylbenzoxazoles as CETP inhibitors: substitution and modification of the alpha-alkoxyamide moiety. Hunt JA; Gonzalez S; Kallashi F; Hammond ML; Pivnichny JV; Tong X; Xu SS; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Sinclair PJ Bioorg Med Chem Lett; 2010 Feb; 20(3):1019-22. PubMed ID: 20036121 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol ester transfer protein: a therapeutic target in atherosclerosis? Vourvouhaki E; Dedoussis GV Expert Opin Ther Targets; 2008 Aug; 12(8):937-48. PubMed ID: 18620517 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of Novel Benzimidazole-2-carboxamide Derivatives and in Vivo Antihyperlipidemic Activity Evaluation. Sheikha GA; Bkhaitan MM; Kalloush H; Hamadneh L; Khalaf RA; Al-Qirim T; Al-Hiari Y Chem Pharm Bull (Tokyo); 2018; 66(4):423-426. PubMed ID: 29607907 [TBL] [Abstract][Full Text] [Related]
13. Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents. Sashidhara KV; Kumar M; Modukuri RK; Srivastava A; Puri A Bioorg Med Chem Lett; 2011 Nov; 21(22):6709-13. PubMed ID: 21983443 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel N-(2-hydroxy-2-p-tolylethyl)-amide and N-(2-oxo-2-p-tolylethyl)-amide derivatives and their antidyslipidemic and antioxidant activity. Narender T; Rajendar K; Sarkar S; Singh VK; Chaturvedi U; Khanna AK; Bhatia G Bioorg Med Chem Lett; 2011 Nov; 21(21):6393-7. PubMed ID: 21930379 [TBL] [Abstract][Full Text] [Related]
15. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents. Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of some 2-azetidinone derivatives as potential antihyperlipidemic agents. Arya N; Dwivedi J; Khedkar VM; Coutinho EC; Jain KS Arch Pharm (Weinheim); 2013 Dec; 346(12):872-81. PubMed ID: 24142910 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of isoflavone fatty acid esters with potential weight loss and hypolipidemic activities. Xiang H; Zhao W; Xiao H; Qian L; Yao Y; Li XB; Liao QJ Bioorg Med Chem; 2010 May; 18(9):3036-42. PubMed ID: 20392645 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of N,N-Disubstituted-4-Arylthiazole-2-Methylamine Derivatives as Cholesteryl Ester Transfer Inhibitors. Wang X; Lin X; Xu X; Li W; Hao L; Liu C; Zhao D; Cheng M Molecules; 2017 Nov; 22(11):. PubMed ID: 29112169 [TBL] [Abstract][Full Text] [Related]
20. Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead--Pro. Barter PJ; Rye KA Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):439-41. PubMed ID: 26848159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]